Biogen Asks Justices To Review Pfizer's MS Drug Win
Biogen is asking the U.S. Supreme Court to overturn Pfizer's victory challenging a patent for Biogen's blockbuster multiple sclerosis treatment Avonex, saying that the Federal Circuit ignored a key word that...To view the full article, register now.
Already a subscriber? Click here to view full article